Brian Park, MD, MPH
Brian Park, MD, MPH
About Brian Park, MD, MPH
Dr. Park is a fellowship-trained and board-certified otolaryngologist who specializes in head and neck surgery and oncology. His interests include the treatment of benign and malignant tumors of the upper aerodigestive tract and neck, thyroid nodules, salivary gland tumors and nasal and sinus disorders. Dr. Park established and directs the multidisciplinary head and neck cancer treatment planning conference at the Vernon Cancer Center at Newton-Wellesley Hospital. His education includes degrees from the Massachusetts Institute of Technology, the State University of New York at Syracuse and the University of Pittsburgh Medical Center.
Clinical Interests:
- Otolaryngology
- Benign tumors of the head and neck
- Head and neck cancer
- Thyroid tumors and cervical soft tissue tumors
- Salivary gland tumors
Treats:
- Adult
Locations
Mass Eye and Ear, Newton
2000 Washington Street
Suite 668
Newton, MA 02462-1626
617-630-1699
Fax: 617-527-8326
Mass Eye and Ear - Wellesley
65 Walnut St
Suite 590
Wellesley, MA 02481
617-630-1699
Fax: 617-527-8326
MEE @ Charles River Medical Associates
246 Maple St
Marlborough, MA 01752
508-460-3872
Fax: 508-357-4150
Medical Education
- MPH, Boston University School of Public Health
- MD, SUNY at Syracuse (Upstate) College of Medicine
- Residency, SUNY Upstate Medical University Hospital
- Fellowship, University of Pittsburgh Medical Center
American Board Certifications
- Otolaryngology, American Board of Otolaryngology
Accepted Insurance Plans
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Harvard Pilgrim Health Plan - other
- Maine Community Health Options (MCHO)
- Senior Whole Health
- Tufts Health Plan
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Publications
-
Park BJ, Chiosea SI, Grandis JR. "Molecular Changes in the Multistage Pathogenesis of Head and Neck Cancer." Molecular Pathology of Early Cancer. 2nd edition. Eds. Grizzle, Srivastava, & van der Sluijs. Amsterdam: IOS Press, currently in press.
Park BJ, Kalish RJ, Vercillo AP. Disseminated Plasmacytoma of the Thyroid. Ear Nose Throat Journal 89(3):137-9, 2010 Mar.
Davidson HC, Park BJ, Johnson JT. Thyroid Cancer: Controversies in the Management of Neck Metastasis. Laryngoscope. 118(12):2161-5, 2008 Dec.
Park BJ, Tatum SA. Oculoauriculovertebral Spectrum in Two Siblings. International Journal of Pediatric Otorhinolaryngology Extra 2 (3): 161-164, 2007.
Park B, Nguyen NT, Dutt P, Merdek KD, Bashar M, Sterpetti P, Tosolini A, Testa JR, Toksoz D. Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation. Journal of Biological Chemistry. 277(47):45361-70, 2002 Nov 22.
Sterpetti P, Hack AA, Bashar MP, Park B, Cheng SD, Knoll JH, Urano T, Feig LA, Toksoz D. Activation of the Lbc Rho exchange factor proto-oncogene by truncation of an extended C terminus that regulates transformation and targeting. Molecular & Cellular Biology. 19(2):1334-45, 1999 Feb.